cyclohexanol has been researched along with Abnormalities, Autosome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Jiang, W; Li, C; Lin, F; Qi, JG; Tian, J; Wang, H; Ye, L; Zhu, H | 1 |
| Dianovský, J; Holecková, B; Piesová, E; Siviková, K | 1 |
| Lederer, J | 1 |
1 review(s) available for cyclohexanol and Abnormalities, Autosome
| Article | Year |
|---|---|
[Sweetening agents: saccharin--cyclamate and its metabolites--aspartame].
Topics: Abnormalities, Drug-Induced; Animals; Aspartame; Chromosome Aberrations; Cricetinae; Cyclamates; Cyclohexanols; Cyclohexanones; Cyclohexylamines; Haplorhini; Mutation; Neoplasms; Rats; Saccharin; Sweetening Agents | 1980 |
2 other study(ies) available for cyclohexanol and Abnormalities, Autosome
| Article | Year |
|---|---|
Acute, subchronic oral toxicity, and genotoxicity evaluations of LPM570065, a new potent triple reuptake inhibitor.
Topics: Administration, Oral; Animals; Antidepressive Agents; Benzoates; Cell Line; Chromosome Aberrations; Cricetulus; Cyclohexanols; Male; Maximum Tolerated Dose; Mutagenicity Tests; Neurotransmitter Uptake Inhibitors; No-Observed-Adverse-Effect Level; Prolactin; Rats, Sprague-Dawley; Testosterone; Toxicity Tests, Acute; Toxicity Tests, Subchronic | 2018 |
Chromosomal changes induced in mouse bone marrow cells following six weeks inhalation of cyclohexanol.
Topics: Administration, Inhalation; Animals; Bone Marrow Cells; Chromosome Aberrations; Cyclohexanols; Mice; Micronuclei, Chromosome-Defective; Sister Chromatid Exchange | 2007 |